Walleye Capital’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.6M Buy
926,800
+786,700
+562% +$24.1M 0.03% 621
2026
Q2
$4.86M Sell
140,100
-3,100
-2% -$83.2K 0.02% 844
2026
Q1
$2.97M Sell
143,200
-403,600
-74% -$9.5M 0.01% 1151
2025
Q4
$17.8M Buy
546,800
+314,300
+135% +$13.5M 0.05% 344
2025
Q3
$13.2M Buy
232,500
+119,800
+106% +$6.14M 0.05% 413
2025
Q2
$5.62M Buy
112,700
+29,300
+35% +$1.32M 0.02% 808
2025
Q1
$2.46M Sell
83,400
-90,100
-52% -$3.35M 0.01% 1275
2024
Q4
$4.2M Buy
173,500
+72,500
+72% +$1.8M 0.01% 1200
2024
Q3
$1.86M Sell
101,000
-8,900
-8% -$159K ﹤0.01% 2031
2024
Q2
$2.22M Buy
109,900
+69,700
+173% +$1.16M ﹤0.01% 2006
2024
Q1
$622K Buy
40,200
+32,700
+436% +$369K ﹤0.01% 3009
2023
Q4
$66.8K Buy
7,500
+6,400
+582% +$47.3K ﹤0.01% 4216
2023
Q3
$6.92K Hold
1,100
– – ﹤0.01% 4538
2023
Q2
$10.3K Buy
+1,100
New +$10.9K ﹤0.01% 3906

Other funds holding HIMS

Walleye Capital's HIMS Position: Q3 2026 in Review

Walleye Capital increased its Hims & Hers Health (HIMS) stake by 3,135% in Q3 2026, buying an estimated $23.9M and bringing the position to 804,793 shares worth $24M. The position accounts for 0.02% of the portfolio, ranked #699.

Walleye Capital first reported a position in HIMS in Q1 2020 and has held it in 21 quarters since. 471 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Walleye Capital held 804,793 shares of Hims & Hers Health worth $24M as of Q3 2026.
  • Walleye Capital bought 779,915 Hims & Hers Health shares in Q3 2026, an estimated $23.9M.
  • Hims & Hers Health made up 0.02% of Walleye Capital's portfolio in Q3 2026, its #699 holding.
  • Walleye Capital first reported a position in Hims & Hers Health in Q1 2020 and has held it in 21 quarters since.
  • 471 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.